登录
 机构网站
  1. 首页
  2. 情报产品
  3. 快讯详情

《MedRxiv，2月18日，Estimating the Case Fatality Risk of COVID-19 using Cases from Outside China》

  • 来源专题：COVID-19科研动态监测
  • 编译者： xuwenwhlib
  • 发布时间：2020-02-19

  • Estimating the Case Fatality Risk of COVID-19 using Cases from Outside China

    Nick Wilson, Amanda Kvalsvig, Lucy Telfar Barnard, Michael Baker

    doi: https://doi.org/10.1101/2020.02.15.20023499

    Abstract

    There is large uncertainty around the case fatality risk (CFR) for COVID-19 in China. Therefore, we considered symptomatic cases outside of China (countries/settings with 20+ cases) and the proportion who are in intensive care units (4.0%, 14/349 on 13 February 2020). Given what is known about CFRs for ICU patients with severe respiratory conditions from a meta-analysis, we estimated a CFR of 1.37% (95%CI: 0.57% to 3.22%) for COVID-19 cases outside of China.

    *注，本文为预印本论文手稿，是未经同行评审的初步报告，其观点仅供科研同行交流，并不是结论性内容，请使用者谨慎使用.

  • 原文来源：https://www.medrxiv.org/content/10.1101/2020.02.15.20023499v1
111浏览量
原文链接
相关报告

  • 《MedRxiv，2月21日，Estimating the case fatality ratio of the COVID-19 epidemic in China》
    • 来源专题：COVID-19科研动态监测
    • 编译者：xuwenwhlib
    • 发布时间：2020-02-22
    • Estimating the case fatality ratio of the COVID-19 epidemic in China Xing Wang, Zihui Ma, Yi Ning, Chen Chen, Rujin Chen, Qiwen Chen, Heng Zhang, Chunming Li, Yan He, Tao Wang, Cheng Tong, Junqing Wu, Yuyan Li, Handong Ma, Shaodian Zhang, Hongxin Zhao doi: https://doi.org/10.1101/2020.02.17.20023630 Abstract Background: Corona Virus Disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan city and rapidly spread throughout China since late December 2019. Crude case fatality ratio (CFR) with dividing the number of known deaths by the number of confirmed cases does not represent the true CFR and might be off by orders of magnitude. We aim to provide a precise estimate of the CFR of COVID-19 using statistical models at the early stage of the epidemic. Methods: We extracted data from the daily released epidemic report published by the National Health Commission P. R. China from 20 Jan 2020, to 20 Feb 2020. Competing risk model were used to obtain the cumulative hazards for death, cure, and cure-death hazard ratio. Then the CFR estimation was calculated based on the slope of the last piece in joinpoint regression model, which reflected the most recent trend of the epidemic. Results: As of 20 Feb 2020, totally 75,570 cases were diagnosed as COVID-19 in China. The CFR of COVID-19 were 8.71% (95% CI: 7.95%-9.64%) in Hubei province, including Wuhan, the epicenter, and 1.21% (95% CI: 1.07%-1.40%) in other areas of China, respectively. We observed obvious decreasing trends of adjusted CFR for COVID-19, with three distinct turning points on January 30, February 6, and February 14 for Hubei province, and one turning point on February 7 for other areas, respectively. Conclusions: Based on analyses of public data, we found that the CFR in Hubei was much higher than that of other regions in China, over 7 times in all estimation. The CFR would follow a downwards trend based on our estimation and recently released data. Nevertheless, at early stage of outbreak, CFR estimates should be viewed cautiously because of limited data source on true onset and recovery time. *注，本文为预印本论文手稿，是未经同行评审的初步报告，其观点仅供科研同行交流，并不是结论性内容，请使用者谨慎使用.
    137浏览量
    原文链接

  • 《Nature，3月19日，Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-03-20
    • Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China Joseph T. Wu, Kathy Leung, Mary Bushman, Nishant Kishore, Rene Niehus, Pablo M. de Salazar, Benjamin J. Cowling, Marc Lipsitch & Gabriel M. Leung Nature Medicine (2020) Abstract As of 29 February 2020 there were 79,394 confirmed cases and 2,838 deaths from COVID-19 in mainland China. Of these, 48,557 cases and 2,169 deaths occurred in the epicenter, Wuhan. A key public health priority during the emergence of a novel pathogen is estimating clinical severity, which requires properly adjusting for the case ascertainment rate and the delay between symptoms onset and death. Using public and published information, we estimate that the overall symptomatic case fatality risk (the probability of dying after developing symptoms) of COVID-19 in Wuhan was 1.4% (0.9–2.1%), which is substantially lower than both the corresponding crude or naïve confirmed case fatality risk (2,169/48,557 = 4.5%) and the approximator1 of deaths/deaths + recoveries (2,169/2,169 + 17,572 = 11%) as of 29 February 2020.
    73浏览量
    原文链接